Aurora-B Kinase Inhibitors for Cancer Chemotherapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|8|14|1514-1525

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.8, Iss.14, 2008-12, pp. : 1514-1525

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of Aurora kinases for the treatment of cancer

By Fancelli Daniele   Moll Jürgen  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 9, 2005-09 ,pp. : 1169-1182

Informa Healthcare

Access to resources Recommend Favorite

Aurora kinase inhibitors: identification and preclinical validation of their biomarkers

By Carpinelli Patrizia   Moll Jürgen  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 1, 2008-01 ,pp. : 69-80

Informa Healthcare

Access to resources Recommend Favorite

Dawn of Aurora kinase inhibitors as anticancer drugs

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 9, 2004-09 ,pp. : 1199-1201

Informa Healthcare

Access to resources Recommend Favorite

Aurora kinase inhibitors in preclinical and clinical testing

By Cheung Chun Hei Antonio   Coumar Mohane Selvaraj   Hsieh Hsing-Pang   Chang Jang-Yang  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 379-398

Informa Healthcare

Access to resources Recommend Favorite

Vertex inhibitors of Aurora-2, glycogen synthase kinase-3 and Src kinase

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 3, 2004-03 ,pp. : 439-443

Informa Healthcare

Access to resources Recommend Favorite